Literature DB >> 21644986

"Grown-up" congenital heart disease and sudden death in a medical examiner's population.

Leslie E Hamilton1, Emma O Lew, Evan W Matshes.   

Abstract

Despite advances in the management of congenital heart disease (CHD), children with CHD who survive into adulthood are at increased risk of sudden death. Sudden death may also be the initial presentation of undiagnosed CHD in some adults. This retrospective descriptive study outlines the spectrum of CHD presenting as sudden death in adults in a medical examiner's population. Despite its rarity (0.2% of all cases investigated between 1991 and 2007), CHD remains an important cause of sudden cardiac death to be recognized at adult autopsy. Bicuspid aortic valve and anomalous coronary anomalies were the most common malformations, comprising 36.9% and 26.2% of cases, respectively. However, a wide spectrum of simple to complex malformations can be seen, with or without prior surgery, and over a wide age spectrum. Once solely a pediatric entity, CHD is now "grown-up" and will likely be diagnosed by forensic pathologists with increased frequency in the future.
© 2011 American Academy of Forensic Sciences.

Entities:  

Mesh:

Year:  2011        PMID: 21644986     DOI: 10.1111/j.1556-4029.2011.01807.x

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  3 in total

Review 1.  General Concepts in Adult Congenital Heart Disease.

Authors:  Ferit Onur Mutluer; Alpay Çeliker
Journal:  Balkan Med J       Date:  2018-01-20       Impact factor: 2.021

2.  Population-based treated prevalence, risk factors, and outcomes of bicuspid aortic valve in a pediatric Medicaid cohort.

Authors:  Avnish Tripathi; Yinding Wang; Jeanette M Jerrell
Journal:  Ann Pediatr Cardiol       Date:  2018 May-Aug

3.  Epidemiology of adult congenital heart disease among the general population in Kuwait.

Authors:  Hasan Ashkanani; Idrees Mohiyaldeen; Hazem ElShenawy; Muath Alanbaei
Journal:  Clin Cardiol       Date:  2021-02-09       Impact factor: 2.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.